SEC Form D · filed July 7, 2021
Cyrus Biotechnology, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Mark Benjamin · Seattle, WAExecGus Tai · Seattle, WADirectorChad Waite · Seattle, WADirectorLucas Nivon · Seattle, WAExec · Director · PromoterYifan Song · Seattle, WAExec · DirectorJoshua F. Sobeck · New York, NYDirectorRobert C. Green · Cambridge, MAExec · Director · PromoterGijs F. Van Thiel · New York, NYExec · DirectorNicholas J. Esterline · WICHITA, KSExecDavid Chao · Houston, TXDirectorEric Bell · Falls Church, VADirectorPaul Martino · SAN FRANCISCO, CAExec · DirectorNicholas Manolelis · Los Angeles, CADirectorJeff Bicksler · Atlanta, GAExec · Director · PromoterJames Kim · Alameda, CAExecBrandon Alexandroff · Longboat Key, FLDirectorEric Bell · Seattle, WADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗